[Current aspects of pseudomonas meningitis].
The article reports on the incidence, the conditions of occurrence, possibilities and successes of treatment with certain (combinations of) antibiotics, in dealing with cases of pseudomonas meningitis. The various possible substances used for treatment are discussed. Rates of penetration and CSF concentrations of azlocillin and cefsulodin are stated. Alternative possibilities for treatment are pointed out.
Brückner
O
O
Borner
K
K
Hoffmann
H G
HG
Trautmann
M
M
Collmann
H
H
D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D001390:Azlocillin / Q000627:therapeutic use; D001431:Bacteriological Techniques; D001930:Brain Injuries / Q000150:complications; D002441:Cefsulodin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005578:Fosfomycin / Q000627:therapeutic use; D006801:Humans; D008581:Meningitis / Q000175:diagnosis / Q000188:drug therapy*; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D011113:Polymyxins; D005578:Fosfomycin; D001390:Azlocillin; D002441:Cefsulodin
Aktuelle Aspekte der Pseudomonasmeningitis.